Federated Hermes Portfolio holdings
AUM
$53.1B
This Quarter Return
+5%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$40.3B
AUM Growth
+$40.3B
(+1.3%)
Cap. Flow
-$447M
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,281
New
170
Increased
712
Reduced
1,071
Closed
190
Top Buys
| 1 |
Amgen
AMGN
|
$170M |
| 2 |
LyondellBasell Industries
LYB
|
$134M |
| 3 |
AT&T
T
|
$116M |
| 4 |
Stanley Black & Decker
SWK
|
$115M |
| 5 |
Pfizer
PFE
|
$88M |
Top Sells
| 1 |
Clorox
CLX
|
$226M |
| 2 |
Broadcom
AVGO
|
$181M |
| 3 |
Gilead Sciences
GILD
|
$158M |
| 4 |
Darden Restaurants
DRI
|
$133M |
| 5 |
KeyCorp
KEY
|
$128M |
Sector Composition
| 1 | Healthcare | 20.2% |
| 2 | Technology | 14.45% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 8.95% |
| 5 | Consumer Discretionary | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Rogers Corp
ROG
$1.39B
| $64.8M | 0.16% |
399,979
+54,513
| +16% | +$8.83M |
|
152
Equifax
EFX
$29.3B
| $64.7M | 0.16% |
274,859
+28,153
| +11% | +$6.62M |
|
153
Chubb
CB
$111B
| $64.6M | 0.16% |
335,370
-3,042
| -0.9% | -$586K |
|
154
Rhythm Pharmaceuticals
RYTM
$6.75B
| $64.2M | 0.16% |
3,891,683
| – | – |
|
155
Repligen
RGEN
$6.54B
| $63.7M | 0.16% |
450,477
-184
| -0% | -$26K |
|
156
RPM International
RPM
$15.8B
| $63.3M | 0.16% |
705,671
+48,418
| +7% | +$4.34M |
|
157
PTC
PTC
$25.4B
| $62.9M | 0.16% |
441,972
+82,253
| +23% | +$11.7M |
|
158
GMS Inc
GMS
$4.2B
| $62.7M | 0.16% |
905,698
+105,938
| +13% | +$7.33M |
|
159
Lam Research
LRCX
$124B
| $62.5M | 0.16% |
97,213
-531
| -0.5% | -$341K |
|
160
Cheniere Energy
LNG
$52.6B
| $62.3M | 0.15% |
409,066
-515
| -0.1% | -$78.5K |
|
161
Royal Caribbean
RCL
$96.4B
| $62.2M | 0.15% |
599,427
+154,201
| +35% | +$16M |
|
162
General Mills
GIS
$26.6B
| $62M | 0.15% |
808,365
-15,185
| -2% | -$1.16M |
|
163
XPO
XPO
$14.8B
| $61.9M | 0.15% |
1,049,563
-231,029
| -18% | -$13.6M |
|
164
Adobe
ADBE
$148B
| $61.7M | 0.15% |
126,153
+6,873
| +6% | +$3.36M |
|
|
HES
165
DELISTED
Hess
HES
| $61.5M | 0.15% |
452,448
+3,465
| +0.8% | +$471K |
|
166
Corcept Therapeutics
CORT
$7.52B
| $61.4M | 0.15% |
2,760,296
| – | – |
|
167
Nike
NKE
$110B
| $61M | 0.15% |
552,749
-81,182
| -13% | -$8.96M |
|
|
168
KeyCorp
KEY
$20.8B
| $60.4M | 0.15% |
6,538,873
-13,870,798
| -68% | -$128M |
|
169
Ares Management
ARES
$38.8B
| $60.2M | 0.15% |
625,000
| – | – |
|
|
SPLK
170
DELISTED
Splunk Inc
SPLK
| $60.2M | 0.15% |
567,120
+35,578
| +7% | +$3.77M |
|
171
Atkore
ATKR
$1.9B
| $60.1M | 0.15% |
385,199
-22,257
| -5% | -$3.47M |
|
172
Prudential Financial
PRU
$37.8B
| $60M | 0.15% |
679,584
+29,446
| +5% | +$2.6M |
|
173
Novanta
NOVT
$4.05B
| $59.8M | 0.15% |
324,744
-71,923
| -18% | -$13.2M |
|
174
Zoom
ZM
$25B
| $59.7M | 0.15% |
878,903
+109,012
| +14% | +$7.4M |
|
175
MoonLake Immunotherapeutics
MLTX
$3.78B
| $59.6M | 0.15% |
1,169,499
+365,000
| +45% | +$18.6M |
|